title: Regression of cardiac involvement by malignant melanoma following lomustine chemotherapy.
abstract: Cardiac involvement by malignant melanoma is usually a premorbid event. We present a case of presumed cardiac involvement by malignant melanoma with regression following chemotherapy as demonstrated by transoesophageal echocardiography.
authors.affiliation: Department of Cardiology, Leicester General Hospital, UK.
authors.forename: M R
authors.initials: MR
authors.lastname: Carpenter
authors.forename: M
authors.initials: M
authors.lastname: Vassallo
authors.forename: I M
authors.initials: IM
authors.lastname: Peat
authors.forename: A J
authors.initials: AJ
authors.lastname: Scriven
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017548:Echocardiography, Transesophageal; D005260:Female; D006338:Heart Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D006801:Humans; D008130:Lomustine / Q000627:therapeutic use*; D008545:Melanoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D008130:Lomustine